Company Overview of EDP Biotech Corporation
EDP Biotech Corporation, an in-vitro cancer diagnostics development company, focuses on the development and commercialization of immunodiagnostic tests for humans and animals. It researches and develops products to identify and purify proteins present in the early stages of biological changes for the production of in-vitro diagnostic tests. The company offers ColoMarker, a tumor marker assay for use in the early detection and monitoring of colorectal cancer. It serves customers through distributors. The company was incorporated in 2005 and is based in Knoxville, Tennessee.
6701 Baum Drive
Knoxville, TN 37919
Founded in 2005
Key Executives for EDP Biotech Corporation
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact EDP Biotech Corporation, please visit edpbiotech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.